GVT
CLB icon

Genesee Valley Trust’s Core Laboratories CLB Stock Holding History

Genesee Valley Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,014
Closed -$305K – 226
2017
Q2 		$305K Sell
3,014
-2,524
-46% -$272K 0.13% 147
2017
Q1 		$639 Buy
5,538
+16
+0.3% +$1.86K 0.44% 65
2016
Q4 		$662 Buy
5,522
+322
+6% +$35.7K 0.47% 64
2016
Q3 		$584K Buy
5,200
+2,840
+120% +$327K 0.36% 99
2016
Q2 		$292K Buy
2,360
+189
+9% +$22.8K 0.19% 168
2016
Q1 		$244K Hold
2,171
– – 0.16% 188
2015
Q4 		$236K Sell
2,171
-200
-8% -$22.9K 0.16% 192
2015
Q3 		$237K Sell
2,371
-50
-2% -$5.44K 0.16% 198
2015
Q2 		$276K Sell
2,421
-92
-4% -$11.2K 0.18% 199
2015
Q1 		$263K Buy
2,513
+80
+3% +$8.52K 0.16% 209
2014
Q4 		$293K Buy
+2,433
New +$320K 0.19% 166

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Genesee Valley Trust's CLB Position: Q3 2017 in Review

Genesee Valley Trust sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 3,014 shares — an estimated $305K sold.

Genesee Valley Trust first reported a position in CLB in Q4 2014 and held it in 11 quarters. The position peaked at $584K in Q3 2016. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Genesee Valley Trust reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Genesee Valley Trust sold 3,014 Core Laboratories shares in Q3 2017, an estimated $305K.
  • Genesee Valley Trust first reported a position in Core Laboratories in Q4 2014 and held it in 11 quarters.
  • Genesee Valley Trust's Core Laboratories position peaked at $584K in Q3 2016.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Genesee Valley Trust's 13F filing for Q3 2017, filed 6 Oct 2017.